Intas Biopharma is a part of Cooperation between three continents for Biosimilar GCSF...

Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of NEUKINE®, biosimilar form of recombinant GCSF....

Ahmedabad based Troikaa Pharmaceuticals Limited has received recognition for its in-house research & development facility from the department of scientific and industrial research (DSIR) under the ministry of science and technology....

Intas Biopharmaceuticals Ltd. becomes sole manufacturer of Pegylated GCSF in India & markets under the brand name "Neupeg"; IBPL plans separate division for Neurology / Nephrology therapeutic segments...